Pharmacy
GSK submits US regulatory filing of Arnuity Ellipta in children with asthma
The FINANCIAL -- GSK on July 24 announced the filing of a supplementary New Drug Application (sNDA) to the US...
U.S. Food and Drug Administration Expands Approval of Yervoy
The FINANCIAL -- Bristol-Myers Squibb Company on July 24 announced that the U.S. Food and Drug Administration (FDA) has expanded...
Novartis receives positive CHMP opinion for Rydapt
The FINANCIAL -- Novartis on July 21 announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human...
Takeda and Schrödinger Announce Multi-year, Multi-Target Research Collaboration
The FINANCIAL -- Takeda Pharmaceutical Company Limited and Schrödinger Inc., a privately-held company dedicated to revolutionizing drug discovery through...
Merck and Pfizer Collaborate with Corning
The FINANCIAL -- Merck, Pfizer and Corning Incorporated on July 20 announced collaborations that have enabled the modernization of pharmaceutical...
GSK announces Board and Committee changes
The FINANCIAL -- GSK on July 21 announces that Dr Laurie Glimcher has been appointed to the Board of the...
Abbott Laboratories Reveals 36% Gain In Q2 Earnings
The FINANCIAL -- Abbott on July 20 announced financial results for the second quarter ended June 30, 2017.
NICE Recommends CINQAERO (reslizumab) for the Treatment of Severe Eosinophilic Asthma
The FINANCIAL -- Teva Pharmaceutical Industries Ltd. on July 20 announced that the National Institute for Health and Care Excellence...
Johnson & Johnson Reports 2017 Second-Quarter Results
The FINANCIAL -- Johnson & Johnson on July 18 announced sales of $18.8 billion for the second quarter of 2017,...
Teva Enhances Board of Directors as All Proposals Approved at Annual General Meeting of Shareholders
The FINANCIAL -- Teva Pharmaceutical Industries Ltd. announced that all proposals were approved at its Annual General Meeting of Shareholders...
Pfizer Announces FDA Accepts Supplemental New Drug Application for XELJANZ
The FINANCIAL -- Pfizer Inc. announced on July 13 that the supplemental New Drug Application (sNDA) for XELJANZ (tofacitinib citrate),...
FDA Advisory Committee Votes in Favor of Pfizer’s MYLOTARG for Acute Myeloid Leukemia
The FINANCIAL -- Pfizer Inc. on July 11 announced that the U.S. Food and Drug Administration’s (FDA) Oncologic Drug Advisory...
Bayer and Netafim develop new smart irrigation approach
The FINANCIAL -- Bayer and the Israeli company Netafim are joining forces to enhance the application of crop protection products...
FDA Grants Full Approval for BLINCYTO
The FINANCIAL -- Amgen on July 11 announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental...
Praxbind is approved as a specific reversal agent for Pradaxa
The FINANCIAL -- Boehringer Ingelheim on July 11 announced final results from RE-VERSE AD.
ADVERTISEMENT
Popular Last 24h
-
Zebra dies after ‘incident’with rhino at zoo
-
Government Contractor Agrees to Pay $1M to Resolve False Claims Act Allegations for Submitting Fraudulent Bids on Prime Vendor Contracts
-
Giant Pandas Will Make Their Public Debut Jan. 24 at Smithsonian’s National Zoo and Conservation Biology Institute
-
Gerald Durrell’s Centenary: a year of celebrations starts today
-
Minnesota Man Sentenced To 15 Months For Trafficking In Stolen Human Remains
-
How the Aging Brain Affects Thinking
-
ICE Acquires the American Financial Exchange (AFX)
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
